Download PDF
Planta Med 2014; 80(15): 1269-1277
DOI: 10.1055/s-0034-1383062
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Effects of Intraperitoneal Thymoquinone on Chronic Neuropathic Pain in Rats

Bahareh Amin
1   Department of Pharmacology and Physiology, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
,
Mohammad Mehdi Heravi Taheri
2   Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
,
Hossein Hosseinzadeh
2   Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
› Author Affiliations
Further Information

Publication History

received 24 March 2014
revised 06 August 2014

accepted 18 August 2014

Publication Date:
01 October 2014 (online)

    Permissions and Reprints

Abstract

In this study, we evaluated the protective effects of thymoquinone, the major constituent of Nigella sativa seeds on the neuropathic pain of rats with chronic constrictive injury of the sciatic nerve. Rats received repeated administration of thymoquinone (1.25, 2.5, and 5 mg/kg, i. p.) once a day for 14 days, beginning immediately after the nerve injury. Mechanical allodynia, cold allodynia, and thermal hyperalgesia were assessed with the von Frey filament, acetone drop, or radiant heat stimulus, respectively. Recent evidence points towards a role of oxidative stress, spinal glia activation, and cell death in the pathogenesis of neuropathic pain. Ionized calcium-binding adapter molecule 1 (a marker of microglia), glial fibrillary acidic protein (a marker of astroglia), Bcl2-associated X protein (a proapoptotic protein), and B-cell lymphoma protein 2 (an antiapoptotic protein) were measured using Western blot on days 3, 7, and 14 post chronic constrictive injury. The changes in the protein levels of malondialdehyde and glutathione, biomarkers of oxidative stress, were assessed by spectrophotometric assay on day 14 post chronic constrictive injury. Repeated treatment with thymoquinone (2.5 and 5 mg/kg) significantly alleviated behavioral signs of neuropathic pain. In the lumbar spinal cord of neuropathic rats, ionized calcium-binding adapter molecule 1 and Bcl2-associated X protein increased on day 3 post chronic constrictive injury, whereas B-cell lymphoma protein 2 did not significantly change. After repeated thymoquinone administration, the elevated Bcl2-associated X protein and ionized calcium-binding adapter molecule reduced on day 3, while the level of B-cell lymphoma protein 2 was even stimulated. Ionized calcium-binding adapter molecule and Bcl2-associated X protein/B-cell lymphoma protein 2 ratio declined by days 7 and 14; consequently, there were no significant differences among groups. No or little change was observed in the glial fibrillary acidic protein content during the study. Chronic constrictive injury produced a significant increase in the levels of malondialdehyde and decrease in the contents of glutathione on day 14. Thymoquinone treatment (2.5 and 5 mg/kg) restored the levels of malondialdehyde. High dose of thymoquinone (5 mg/kg) also reversed the decreased glutathione in the injured animals. Our results indicate that, microglia, apoptotic factors, and oxidative stress rather than astroglia contribute to the pathogenesis of chronic constrictive injury, and thymoquinone plays an anti-nociceptive role possibly by antioxidant effects and inhibition of microglia activity.

Key words

thymoquinone - Nigella sativa - Ranunculaceae - chronic constriction injury - apoptosis - oxidative stress - glia
 

  • References

  • 1 Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004; 140: 441-451
    CrossrefPubMedGoogle Scholar
  • 2 Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807-819
    CrossrefPubMedGoogle Scholar
  • 3 Nergiz C, Ötleş S. Chemical composition of Nigella sativa L. seeds. Food Chem 1993; 48: 259-261
    CrossrefPubMedGoogle Scholar
  • 4 el Daly ES. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg 1998; 53: 87-93
    PubMedGoogle Scholar
  • 5 Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14: 323-328
    CrossrefPubMedGoogle Scholar
  • 6 Mousavi S, Tayarani-Najaran Z, Asghari M, Sadeghnia H. Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced PC12 cells death. Cell Mol Neurobiol 2010; 30: 591-598
    CrossrefPubMedGoogle Scholar
  • 7 Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, Mansouri MT. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit 2005; 11: 106-110
    PubMedGoogle Scholar
  • 8 Awad E, Austin D, Lyndon AR. Effect of black cumin seed oil (Nigella sativa) and nettle extract (Quercetin) on enhancement of immunity in rainbow trout, Oncorhynchus mykiss (Walbaum). Aquaculture 2013; 388–391: 193-197
    PubMedGoogle Scholar
  • 9 Mahmoud MR, El-Abhar HS, Saleh S. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol 2002; 79: 1-11
    CrossrefPubMedGoogle Scholar
  • 10 Meddah B, Ducroc R, El Abbes Faouzi M, Eto B, Mahraoui L, Benhaddou-Andaloussi A, Martineau LC, Cherrah Y, Haddad PS. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol 2009; 121: 419-424
    CrossrefPubMedGoogle Scholar
  • 11 Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 2000; 55: 379-382
    PubMedGoogle Scholar
  • 12 Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa . J Ethnopharmacol 2001; 76: 45-48
    CrossrefPubMedGoogle Scholar
  • 13 de Sousa DP, Nóbrega FF, Santos CC, Benedito RB, Vieira YW, Uliana MP, Brocksom TJ, de Almeida RN. Antinociceptive activity of thymoquinone and its structural analogues: A structure-activity relationship study. Trop J Pharmaceutic Res 2012; 11: 605-610
    PubMedGoogle Scholar
  • 14 Berger JV, Deumens R, Goursaud S, Schafer S, Lavandʼhomme P, Joosten EA, Hermans E. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1. J Neuroinflammation 2011; 8: 33
    CrossrefPubMedGoogle Scholar
  • 15 Liu F, Yuan H. Role of glia in neuropathic pain. Front Biosci 2014; 19: 798-807
    CrossrefPubMedGoogle Scholar
  • 16 Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010; 10: 167-184
    CrossrefPubMedGoogle Scholar
  • 17 Ghinea N, Lipworth W, Kerridge I. Evidence, regulation and ‘rational’ prescribing: the case of gabapentin for neuropathic pain. J Eval Clin Pract Epub 2 July 2014 DOI: 10.1111/jep.12223.
    PubMedGoogle Scholar
  • 18 Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia 2012; 83: 888-895
    CrossrefPubMedGoogle Scholar
  • 19 Taiwe GS, Bum EN, Talla E, Dimo T, Dawe A, Sinniger V, Bonaz B, Boumendjel A, De Waard M. Nauclea latifolia Smith (Rubiaceae) exerts antinociceptive effects in neuropathic pain induced by chronic constriction injury of the sciatic nerve. J Ethnopharmacol 2014; 151: 445-451
    CrossrefPubMedGoogle Scholar
  • 20 Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003; 424: 778-783
    CrossrefPubMedGoogle Scholar
  • 21 Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003; 306: 624-630
    CrossrefPubMedGoogle Scholar
  • 22 Wodarski R, Clark AK, Grist J, Marchand F, Malcangio M. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur J Pain 2009; 13: 807-811
    CrossrefPubMedGoogle Scholar
  • 23 Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol 2009; 623: 65-72
    CrossrefPubMedGoogle Scholar
  • 24 Mika J, Wawrzczak-Bargiela A, Osikowicz M, Makuch W, Przewlocka B. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav Immun 2009; 23: 75-84
    CrossrefPubMedGoogle Scholar
  • 25 Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991; 565: 1-7
    CrossrefPubMedGoogle Scholar
  • 26 Garrison CJ, Dougherty PM, Carlton SM. GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp Neurol 1994; 129: 237-243
    CrossrefPubMedGoogle Scholar
  • 27 Wang W, Mei XP, Chen L, Tang J, Li JL, Wu SX, Xu LX, Li YQ. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response. Pain Physician 2012; 15: E995-E1006
    PubMedGoogle Scholar
  • 28 Keane RW, Kraydieh S, Lotocki G, Bethea JR, Krajewski S, Reed JC, Dietrich WD. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 2001; 60: 422-429
    PubMedGoogle Scholar
  • 29 Siniscalco D, Fuccio C, Giordano C, Ferraraccio F, Palazzo E, Luongo L, Rossi F, Roth KA, Maione S, de Novellis V. Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain. Pharmacol Res 2007; 55: 158-166
    CrossrefPubMedGoogle Scholar
  • 30 de Novellis V, Siniscalco D, Galderisi U, Fuccio C, Nolano M, Santoro L, Cascino A, Roth KA, Rossi F, Maione S. Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II. Neuropharmacology 2004; 46: 468-479
    CrossrefPubMedGoogle Scholar
  • 31 Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol 2006; 148: 1022-1032
    PubMedGoogle Scholar
  • 32 Chao CC, Hu S, Peterson PK. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 1995; 58: 65-70
    PubMedGoogle Scholar
  • 33 Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61: 33-36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Singh S, Das SS, Singh G, Schuff C, de Lampasona MP, Cataln CA. Composition, in vitro antioxidant and antimicrobial activities of essential oil and oleoresins obtained from black cumin seeds (Nigella sativa L.). Biomed Res Int 2014; 2014: 918209
    PubMedGoogle Scholar
  • 35 Radad K, Hassanein K, Al-Shraim M, Moldzio R, Rausch WD. Thymoquinone ameliorates lead-induced brain damage in Sprague Dawley rats. Exp Toxicol Pathol 2013; 66: 13-17
    PubMedGoogle Scholar
  • 36 Mansour MA, Nagi MN, El-Khatib AS, Al-Bekairi AM. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochem Funct 2002; 20: 143-151
    CrossrefPubMedGoogle Scholar
  • 37 Vaillancourt F, Silva P, Shi Q, Fahmi H, Fernandes JC, Benderdour M. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. J Cell Biochem 2012; 112: 107-117
    PubMedGoogle Scholar
  • 38 El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, El-Sayed M, Takewaki T. Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. Int Immunopharmacol 2005; 5: 195-207
    CrossrefPubMedGoogle Scholar
  • 39 Abdel-Zaher AO, Mostafa MG, Farghly HM, Hamdy MM, Omran GA, Al-Shaibani NK. Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice. Eur J Pharmacol 2013; 702: 62-70
    CrossrefPubMedGoogle Scholar
  • 40 Hosseinzadeh H, Parvardeh S, Asl MN, Sadeghnia HR, Ziaee T. Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 2007; 14: 621-627
    CrossrefPubMedGoogle Scholar
  • 41 Dariani S, Baluchnejadmojarad T, Roghani M. Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy. J Mol Neurosci 2013; 51: 679-686
    CrossrefPubMedGoogle Scholar
  • 42 Abdel-Fattah AM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol 2000; 400: 89-97
    CrossrefPubMedGoogle Scholar
  • 43 Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 1983; 16: 109-110
    CrossrefPubMedGoogle Scholar
  • 44 Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107
    CrossrefPubMedGoogle Scholar
  • 45 Choi Y, Yoon YW, Na HS, Kim SH, Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994; 59: 369-376
    CrossrefPubMedGoogle Scholar
  • 46 Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88
    CrossrefPubMedGoogle Scholar
  • 47 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
    CrossrefPubMedGoogle Scholar
  • 48 Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278
    CrossrefPubMedGoogle Scholar
  • 49 Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582: 67-78
    CrossrefPubMedGoogle Scholar